ENTrigue Surgical Inc., HemCon sales and marketing update

HemCon granted ENTrigue exclusive rights to develop and commercialize HemCon's Synaero Hemostatic Gel for the ear, nose and throat surgical market in the U.S. and select European countries. The surfac...